FEMY
Price
$0.71
Change
-$0.03 (-4.05%)
Updated
Aug 15 closing price
Capitalization
23.13M
82 days until earnings call
LUCD
Price
$1.02
Change
+$0.04 (+4.08%)
Updated
Aug 15 closing price
Capitalization
103.93M
93 days until earnings call
Interact to see
Advertisement

FEMY vs LUCD

Header iconFEMY vs LUCD Comparison
Open Charts FEMY vs LUCDBanner chart's image
Femasys
Price$0.71
Change-$0.03 (-4.05%)
Volume$236.63K
Capitalization23.13M
Lucid Diagnostics
Price$1.02
Change+$0.04 (+4.08%)
Volume$759.32K
Capitalization103.93M
FEMY vs LUCD Comparison Chart in %
Loading...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FEMY vs. LUCD commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEMY is a Hold and LUCD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (FEMY: $0.71 vs. LUCD: $1.02)
Brand notoriety: FEMY and LUCD are both not notable
FEMY represents the Pharmaceuticals: Other, while LUCD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FEMY: 85% vs. LUCD: 67%
Market capitalization -- FEMY: $23.13M vs. LUCD: $103.93M
FEMY [@Pharmaceuticals: Other] is valued at $23.13M. LUCD’s [@Medical/Nursing Services] market capitalization is $103.93M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.31B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FEMY’s FA Score shows that 0 FA rating(s) are green whileLUCD’s FA Score has 0 green FA rating(s).

  • FEMY’s FA Score: 0 green, 5 red.
  • LUCD’s FA Score: 0 green, 5 red.
According to our system of comparison, LUCD is a better buy in the long-term than FEMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FEMY’s TA Score shows that 4 TA indicator(s) are bullish while LUCD’s TA Score has 6 bullish TA indicator(s).

  • FEMY’s TA Score: 4 bullish, 5 bearish.
  • LUCD’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, LUCD is a better buy in the short-term than FEMY.

Price Growth

FEMY (@Pharmaceuticals: Other) experienced а -20.47% price change this week, while LUCD (@Medical/Nursing Services) price change was +2.35% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +4.58%.

Reported Earning Dates

FEMY is expected to report earnings on Nov 06, 2025.

LUCD is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LUCD($104M) has a higher market cap than FEMY($23.1M). LUCD YTD gains are higher at: 24.588 vs. FEMY (-35.445). FEMY has higher annual earnings (EBITDA): -18.54M vs. LUCD (-60.92M). LUCD has more cash in the bank: 25.2M vs. FEMY (3.82M). FEMY has less debt than LUCD: FEMY (7.67M) vs LUCD (35.3M). LUCD has higher revenues than FEMY: LUCD (4.17M) vs FEMY (1.7M).
FEMYLUCDFEMY / LUCD
Capitalization23.1M104M22%
EBITDA-18.54M-60.92M30%
Gain YTD-35.44524.588-144%
P/E RatioN/AN/A-
Revenue1.7M4.17M41%
Total Cash3.82M25.2M15%
Total Debt7.67M35.3M22%
TECHNICAL ANALYSIS
Technical Analysis
FEMYLUCD
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LUCD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBIIF34.50N/A
N/A
Obic Co. Ltd.
RFLXF0.03N/A
N/A
Reflex Advanced Materials Corp.
AWLRF0.38N/A
N/A
Awale Resources Limited
TATYY28.98-0.22
-0.75%
Tate & Lyle, PLC
ELEMF1.49-0.02
-1.32%
ELEMENTAL ALTUS ROYALTIES CORP.

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OFIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OFIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-4.35%
OFIX - FEMY
30%
Poorly correlated
+1.50%
CSTL - FEMY
30%
Poorly correlated
+1.36%
LUCD - FEMY
30%
Poorly correlated
+3.96%
OM - FEMY
29%
Poorly correlated
+3.10%
GH - FEMY
29%
Poorly correlated
-2.45%
More

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
+3.96%
NOTV - LUCD
32%
Poorly correlated
+2.72%
FEMY - LUCD
30%
Poorly correlated
-4.35%
CRL - LUCD
27%
Poorly correlated
+0.56%
INGN - LUCD
26%
Poorly correlated
-2.74%
NNOX - LUCD
24%
Poorly correlated
-1.78%
More